MINNEAPOLIS--(BUSINESS WIRE)--Medtronic Inc. (NYSE:MDT) today announced the start of its CONNECT SM trial, which will further substantiate the impact of Medtronic’s most advanced devices with Conexus™ ...
DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of ...
I recently had the chance to try out the latest in diabetes tech from Medtronic, conducting a 14-day test drive of the new Minimed Connect data display platform. This new system shows both insulin ...
The technology was approved by FDA in June and unveiled at the Scientific Sessions of the American Diabetes Association. Medtronic today announced that its MiniMed Connect technology, which displays ...
Medtronic plc. MDT recently made a major development in the field of diabetes management. The company reached an outcome-based agreement with Blue Cross and Blue Shield of Minnesota in relation to the ...
Unique partnership with Medtronic will enable continuous glucose monitoring (CGM) sensors based on Abbott (ABT)'s FreeStyle Libre sensing technology to integrate with Medtronic's insulin delivery ...
Sugar.IQ — the digital diabetes assistant for Guardian Connect system users that is jointly supported by Medtronic and IBM Watson — has a new feature that uses artificial intelligence to predict ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback